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Abstract
Many biological and clinical outcomes are based not on single proteins, but on modules of proteins embedded in protein
networks. A fundamental question is how the proteins within each module contribute to the overall module activity. Here,
we study the modules underlying three representative biological programs related to tissue development, breast cancer
metastasis, or progression of brain cancer, respectively. For each case we apply a new method, called Network-Guided
Forests, to identify predictive modules together with logic functions which tie the activity of each module to the activity of
its component genes. The resulting modules implement a diverse repertoire of decision logic which cannot be captured
using the simple approximations suggested in previous work such as gene summation or subtraction. We show that in
cancer, certain combinations of oncogenes and tumor suppressors exert competing forces on the system, suggesting that
medical genetics should move beyond cataloguing individual cancer genes to cataloguing their combinatorial logic.
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Introduction
Biological complexity, it is thought, is not a simple function of
the number of genes in a genome. It likely stems from a variety of
factors, including the number of protein states and, as importantly,
the number of combinations in which proteins assemble into
functional modules [1,2]. In development, it is largely combina-
torial modules of transcription factors that give rise to the diversity
of tissues [3]. Protein combinations are equally instrumental in the
pathogenesis of human disease, for instance the inappropriate
fusion of Bcr and Abl that leads to chronic myelogenous leukemia
[4] or the abnormal interactions acquired by the huntington
protein in Huntington’s Disease [5].
An intriguing question is how the states of single proteins jointly
determine the higher level states of protein modules. In classic
biological studies, protein modules have been shown to encode
basic logic functions such as AND, OR and NOT which are
further combined within larger modules to code for complex
programs [6]. A canonical example is the pigment cell module in
sea urchin embryos [7]. There, the SuH/Groucho repressor
complex forms in the absence of N
ic which, in turn, is determined
by the lack of Delta signaling. Once Delta signaling is received, the
SuH/Groucho repressor complex is displaced by the SuH/N
ic
activator complex, which activates the GCM gene to induce
pigment cell specification. In this case, the module activity can be
summarized using basic AND and NOT functions:
IF Groucho AND SuH AND NOT N
ic THEN NOT
GCM (NOT
Pigment Cell)
IF N
ic AND SuH THEN GCM (Pigment Cell)
Another example of network-encoded logic is the BAF
chromatin remodeling complex [8]. The stem-cell specific version
of the complex (esBAF) is characterized by presence of BRG1 but
not BRM, and BAF155 but not BAF170 [9]. The neuron-
progenitor version (npBAF) contains both BAF155 and BAF170
and also incorporates BRM and BAF60C while excluding
BAF60B [10]. Pathological forms of BAF have also been
characterized. For example the core subunit of the complex,
SNF5, is inactive in malignant rhabdoid tumors, a highly
aggressive cancer of early childhood [11].
Given the importance of protein modules and their outputs, a
major activity within the field of Systems Biology has been to
identify such modules systematically through analysis of global
data sets [12–16]. Many computational methods have been
developed to integrate a panel of gene expression profiles with
protein-protein interaction maps or pathway databases, with the
goal of associating modules with a biological or clinical outcome
[17–30]. Among these, several approaches have investigated how
protein modules can be used to classify samples. In these methods,
each module defines a set of interacting proteins whose expression
levels are combined to determine the module activity, which in
turn is used to predict the phenotypic class of the sample.
However, with one recent exception [28] these methods have
assumed that the activity of every module of interest is
homogenous and follows a single general function, such as the
sum of gene expression levels in a module [20,25] or the difference
in expression levels across interacting genes in a module [15,27]
(Figure 1A). While these simple functions (as well as more
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pressed or perturbed modules, they do not provide the rich logical
framework known to occur in biological systems.
Here, we develop a novel method called Network-Guided Forests
(NGF) to learn the network modules whose logic specifies key
biological and clinical outcomes. NGF integrates key ideas from
Random Forests (RF) [31] with biological constraints induced by a
protein-protein interaction network— the first use of protein
networks in ensemble learning [32]. Rather than relying on a
general measure of module activity, NGF fits specific logic functions
to each module directly from data. In contrast to Chowdhury et al.
[28] who learned network state functions to select informative gene
sets that were further used to train a neural network model, the
functions identified here are used directly in the classification
process. NGF can also readily be applied to continuous gene
expression measurements and problems with more than two classes.
Using NGF, we explore the functions used in diverse biological
programs related to tissue differentiation, breast cancer metastasis,
or mesenchymal transformation of brain tumors. For each case a set
of network modules is identified which captures known causal
mechanisms of development or disease and – in contrast to classical
Random Forests – provides robust biomarkers across different
sample cohorts. The modules implement diverse logic functions
Author Summary
Biological outcomes are often determined by modules of
proteins working in combination. In classic biological
studies, these modules have been shown to encode a
diverse repertoire of logic functions which provide the
means to express complex regulatory programs using a
limited number of proteins. Here, we integrate gene
expression profiles and physical protein interaction maps
to provide a systematic and global view of combinatorial
network modules underlying representative developmen-
tal and cancer programs. We develop a new method that
associates decision trees with concise network regions to
identify network decision modules predictive of biological
or clinical outcome. The resulting network signatures
prove robust across different sample cohorts and capture
causal mechanisms of development or disease. Further-
more, we find that the most predictive network decision
functions rely on both coherent and opposing gene
activities. Notably, in cancer progression the predictive
gene associations often map to physical interactions
between known oncogenes and tumor suppressors, where
the combined activity of these genes determines disease
outcome.
Figure 1. Method overview. (A) Representative module activity functions used by previous methods are compared to logic functions considered
in this study. Logic functions capture a wide range of differential activities that are not captured by any single function. Our method uses logic
functions directly in the classification process and extends to classification scenarios with more than two classes. (B) Network-guided search for
decision trees associated with network modules. Each decision tree maps to a connected subnetwork. (C) Decision tree and the corresponding logic
function represented as a truth table. The decision tree assigns each sample to a class by performing a series of tests where each test determines
whether the expression of a selected gene is higher (.) or lower (,) than a threshold value. The gene is interpreted as being up-regulated if its
expression is above the threshold. Otherwise the gene is down-regulated. Each path from root to leaf in the tree defines a single decision rule which
maps to a different row in the truth table. Decision trees are typically not grown to the full extent and thus not all genes must be tested along each
path if a subset of the genes is sufficient to determine the output.
doi:10.1371/journal.pcbi.1002180.g001
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module output depends on expression increases for some genes and
concomitant decreases for others. Notably in cancer progression,
the most predictive decision functions can often be linked to
interactionsbetweenknownoncogenesand tumorsuppressors,such
that the combined activity of both types of genes determines the
disease outcome.
Results
Overview of NGF approach and data
The NGF framework learns a set of decision trees (the ‘‘forest’’)
in which each tree maps to a connected component of the protein-
protein interaction network (Figure 1B). The decision tree
specifies a function that determines the output of the network
component based on the activity of its genes. In turn, the collection
of all tree outputs is used to predict the cell type or disease state of
the biological sample (the ‘‘class’’). When binary gene activities
and two-class decision problems are considered, decision trees
map directly to Boolean logic functions [33] (Figures 1C, S1). In
general, however, decision trees can be readily applied to
continuous gene activity values and multi-class scenarios [34].
To build a decision tree, NGF selects an initial gene to partition
the samples by high versus low gene expression and it scores how
well this partition separates the classes. Samples for which the
expression of the selected gene is high are placed in the right
subtree while those for which the expression is low are placed in
the left subtree. NGF then conducts a network-guided search
which progressively adds new genes to the tree to improve its
discrimination between classes, with new genes chosen from the
network neighborhood of genes already in the tree (Figure 1B;
Materials and Methods). Many trees are built, starting from many
different initial genes, to define the forest.
By construction, decision trees include genes that influence a
phenotypic outcome both individually and through multi-way
interactions with other genes [35]. As in the standard Random
Forests algorithm, NGF uses a permutation-based procedure to
assess the importance of each gene on the classification accuracy of
the forest (Materials and Methods). Motivated by [36], we also
assess the importance of pairs of genes in a tree — in our study
these pairs are constrained by the network neighborhood. Genes
and gene pairs with significantly high importance scores are placed
into clusters that capture similar patterns of presence/absence
across the forest of decision trees. Each cluster aggregates genes
that fall into the same network region and, in combination, have
predictive power over the sample class. Hence these clusters are
termed ‘‘consensus decision modules’’.
To apply this framework to study the logic of biological
decisions, we obtained mRNA expression data from three diverse
studies related to (1) Development of germ layers, (2) Breast cancer
metastasis, or (3) Progression of glioma, respectively (Materials and
Methods). While these studies collectively span a wide range of
human biology, each makes use of mRNA expression profiles to
discriminate between classes of development (study 1) or disease
(studies 2 and 3). To provide a complementary protein network,
we downloaded a set of 5227 physical interactions measured
among pairs of human transcription factors, many of which have
been recently reported using the mammalian two hybrid system
[15]. NGF was used to combine this protein network with each
expression data set to derive a forest of decision trees and
corresponding network decision modules for each study
(Figure 2). To allow comparison to other module-finding
approaches, we also obtained a network of 57,228 human
protein-protein interactions as used previously in [20,24]. Further
information about each expression and network data set is
provided below and in Table S1.
Network modules reveal causal mechanisms of
development and are robust
Tissue differentiation is largely governed by combinatorial
interactions among transcription factors [1]. To identify protein
modules involved in tissue development, we applied NGF to qRT-
PCR expression profiles collected for 34 human tissues (Ravasi et
al. dataset [15]) classified according to their embryonic origin:
endoderm, mesoderm, non-neural ectoderm, central nervous
system (CNS) or cell lines (Figure 2). NGF integrated these data
with the transcription factor protein interaction network (Table
S1) to reveal a set of 16 consensus decision modules, each
containing genes frequently used in combination to predict tissue
origin (Figures 2, 3A). Among these modules, we recognized a
number of well-established regulatory complexes with known
decisive roles in development (Table 1). For instance, the single
most predictive interaction identified was between HOXC8 and
SMAD1, a transcriptional heterodimer that is known to induce
osteoblast differentiation [37]. Also consistent with the logic
identified by NGF (Figure 2), HOXC8 is highly expressed in
ectoderm and mesoderm during mouse early embryogenesis [38].
A systematic functional analysis of the modules (Materials and
Methods) indicated that they were highly enriched for genes whose
perturbation is linked to prenatal lethality or improper organ
development in mammals (Figure 3B), as reported in the Mouse
Genome Informatics (MGI) database [39] — an established source
of functional associations for both mouse genes and their human
orthologs [13]. Gene Ontology analysis [40] indicated that the
network was significantly enriched for pattern-specification
homeobox genes (19/48 genes) and other developmentally
important gene categories, for example embryonic morphogenesis
and skeletal system development (Figure S2). Furthermore, we
found that the genes used by NGF to identify a particular tissue
origin (endoderm, mesoderm, ectoderm) were generally implicated
in developmental processes specific for that type of tissue
(Figure 3C and Text S1).
To examine the robustness of these decision modules, we
investigated whether they could be reproduced from random
subsets of the input gene expression profiles, as well as from an
independent set of profiles. We found that the protein combina-
tions co-occurring within the same module were highly reproduc-
ible across subsets of expression profiles, much more so than the
protein combinations identified by the standard Random Forest
algorithm (Figure S3). Further, NGF was used to analyze a large
expression profiling study by Muller et al. [13] consisting of 153
types of multipotent stem cells, where each cell type is attributed to
the mesoderm, endoderm or ectoderm. We analyzed the single
proteins and protein pairs identified as being significantly
predictive in the previous dataset (Ravasi et al.; Figure 3A) and
compared them to the same number of top scoring proteins and
protein pairs identified in the dataset from Muller et al. While only
two of ten significant proteins (20%) were identified in common
based on single feature analysis, we found that 14 of 38 proteins
(37%) were reproduced based on importance scores for pairs of
genes (Figures 3D, S4). Among non-trivial decision modules (i.e.,
those with three or more proteins), five out of six (83%) were
recovered in both studies (Figures 3D, S4). In comparison, the
standard Random Forest algorithm, which did not use the
network, was not able to identify any reproducible gene
combinations (Figure 3E; Text S1). Moreover, randomized
runs of NGF (in which the assignment of expression profiles to
network nodes was permuted) identified only 8% of the same
Protein Networks as Logic Functions
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Taken together, these results indicate that the tissue-specific
network expression pattern identified by NGF is both biologically
relevant and robust across sample cohorts.
Informative and robust models of breast cancer and
glioma progression
While normal developmental programs are tightly regulated,
pathological states including cancer can reflect regulatory
programs gone awry. To investigate how well NGF can predict
cancer progression and identify robust biomarkers, we selected a
cohort of 295 nonfamilial breast cancer patients (van de Vijver
dataset [41]), for 78 of whom metastasis has been detected during
a follow-up visit within five years after surgery. The accuracy of
NGF and other algorithms in classifying metastatic vs. non-
metastatic samples was assessed using a five-fold cross validation
scheme repeated 100 times. The average area under the ROC
curve (AUC) for Network-Guided Forests was 0.74 (Figures 4A,
S5A), which was better by 3–6% than previously reported results
for a variety of standard and network/pathway-based classification
methods [24,25,27].
Interestingly, the performance of NGF was on par with regular
Random Forests (non-network-based), as well as with NGF applied
to randomized networks in which the edges were permuted while
maintaining the original degree distribution (NGF**; Figures 4A,
S5A). Thus, it appears that the decision tree framework used by all
three methods is able to find predictive feature sets regardless of
the restriction imposed by the protein-protein interaction network.
However, in contrast to Random Forests we found that NGF
identified many more genes with known roles in breast cancer or
cancer in general (Figure 4B). Closer inspection showed that
known cancer genes are often not among the most differentially
expressed, but are predictive in combination with their network
neighbors so that they appear among the most abundant genes in
the forest (Figure 4B). In contrast, permuted networks identified
far fewer cancer genes among the most abundant features,
indicating that the network neighborhood provides crucial
information which guides NGF to the biology of disease.
To study the robustness of markers identified by NGF, we
compared the most abundant features from the van de Vijver
dataset to those found in an independent study of 106 metastatic
and 180 non-metastatic breast cancer samples described by Wang
et al. [42]. The correlation of the resulting gene rankings based on
their occurrences in the forest was 0.73 for NGF versus 0.01 for
the regular Random Forest algorithm. Altogether, 31 genes were
shared among the 100 most abundant genes from the two datasets,
compared to 2 common genes identified by Random Forests
(Figure 4C). Thus, the regularization imposed by the network
serves to focus the training process on true cancer susceptibility
genes, which are observed reproducibly across data sets.
These general findings were also observed in a different process
related to cancer progression: mesenchymal transformation of
brain tissue. Mesenchymal transformation has been associated
with exceedingly aggressive forms of high-grade gliomas (HGGs) –
Figure 2. Network decision modules underlying embryonic origin, breast cancer metastasis and mesenchymal transformation of
brain tumors. Expression profiles for each of the three case studies are combined with a network of protein-protein interactions among human
transcription factors. Network-guided forests are used to identify key network modules that are most important for correct sample classification
(representative modules are shown for each study). Grey edges indicate physical protein-protein interactions, blue edges indicate protein
combinations that often co-occur in the same decision trees and are most important for classification (as indicated by the permutation test). Node
color indicates protein importance whereas edge width indicates the importance of a protein combination. Each module is assigned a decision tree
that specifies the output of the module based on the activity of its genes (see also Figure S1).
doi:10.1371/journal.pcbi.1002180.g002
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network activity patterns leading to the mesenchymal phenotype,
we trained the NGF framework on expression profiles of 76 HGG
samples previously assigned to one of three groups: proneural,
proliferative or mesenchymal [43]. Proneural and proliferative
samples were grouped together as ‘‘non-mesenchymal’’ and
treated as a control group for detecting the mesenchymal network
signature. As with breast cancer, we found that NGF outper-
formed the benchmark classifier Naı ¨ve Bayes in terms of
classification accuracy and performed as well as the standard
Random Forest algorithm (Figures S5B, S6A). Furthermore,
NGF identified more cancer susceptibility genes among the top
ranked features (Figures S6B).
Logic functions embedded in protein networks
We next wished to determine whether there were particular
network decision functions that were common across biological
data sets or, alternatively, which functions were distinct. For this
purpose, protein interactions in the decision trees were function-
ally categorized according to the sign of their proteins in classifying
a given phenotype (Figure 5A; Text S1). The three functional
combinations were: ‘‘A AND B’’, ‘‘NOT A AND NOT B’’ and ‘‘A
AND NOT B’’. We asked which of these functions can best
separate the samples into class-homogeneous groups and which
types of functions are preferred.
Indeed, we found that particular functions were overrepresented
among the most predictive gene combinations and that these
functions differed across the different biological processes
investigated (Figure S7). Interestingly, across all cancer datasets,
decision functions used to predict the more aggressive phenotype
were more likely to be associated with ‘‘A AND NOT B’’ logic
than other functions (Figures 5A, S7). Such opposing gene
combinations were instrumental in many decision modules
identified by NGF. For instance, in breast cancer a highly
predictive consensus decision module was identified among C/
EBPb, STAT5A, and HSF1 (Figure 2) – three genes whose
activity has been shown to directly influence cancer progression
[44–46]. The unfavorable metastatic phenotype is associated
with high levels of C/EBPb and HSF1 and low levels of
STAT5A (Figures 2, S1A). Consistent with this prediction,
upregulation C/EBPb can induce acquisition of an invasive
phenotype [44], and expression of HSF1 is required for cellular
transformation and tumorigenesis in HER2-positive breast
tumors [46]. STAT5, on the other hand, has been shown to
inhibit invasive characteristics of human breast cancer cells and
is often lost during metastatic progression [45]. Similarly, for the
brain tumor case study, NGF identified a key logic function
which associates the mesenchymal phenotype with the upregu-
lation of STAT3 and downregulation of SS18L1 (Figures 2,
S1B). STAT3 is a known oncogene recently identified as a
driver of mesenchymal transformation in brain tumors [14],
while SS18L1 is a protein normally required for calcium-
dependent dendritic growth and branching in cortical neurons
[47].
Across all functional categories, we found that the top scoring
decision functions identified in cancer were enriched for
interactions between known cancer-related genes (P=4.92610
24
and P=1.94610
23 for the mesenchymal transformation of brain
tumors [43] and breast cancer metastasis [42], respectively).
Moreover, opposing functional combinations (‘‘A AND NOT B’’)
predictive of the mesenchymal transformation were significantly
enriched for interactions between products of oncogenes and
tumor suppressors (Figure 5B). In turn, the coherent combina-
tions ‘‘A AND B’’ or ‘‘NOT A AND NOT B’’ were enriched for
known interactions between oncogenes or between tumor
suppressor genes, respectively (Figure 5B; Table S2). These
results support a model in which the aberrant cancer-related
activity is caused by combinations of oncogenes and tumor
suppressors co-occurring in the same pathways [48-50] and
suggest that decision modules reported by NGF may be an
excellent means to identify such combinations for further study
(Table S2).
Table 1. Network modules corresponding to known regulatory complexes in development.
Module Known role/tissue specificity References
GATA3-LMO1-TAL1 Activates the transcription of RALDH2 in T-cell Acute Lymphoblastic Leukemia [64]
HOX-PBX-MEIS-SMAD Potential for higher order complexes that modulate tissue activity [54]
HOXA5-TWIST1 HOXA5 partially restores inhibitory effects of Twist on p53 target genes in breast cancer cells [65]
HOXA9-PBX1-MEIS1 Regulates CYBB transcription in myeloid differentiation [66]
HOXA10-SIRT2 Promotes histone deacetylation; represses gene transcription [67]
HOXB7-NFKBIA NF-kBa n dI kB-a increase transactivation by HOXB7 [68]
HOXC8-SMAD1 Promotes osteoblast differentiation [37]
HOXC8-SMAD6 Hoxc8 represses BMP-induced expression of Smad6 [69]
PAX3-SOX10 Mediates activation of c-RET enhancer in neural crest precursor cells [70]
doi:10.1371/journal.pcbi.1002180.t001
Figure 3. Network modules capture causal developmental factors and are reproducible. (A) Consensus network modules underlying
tissue origin (modules of size greater than 2 are encircled). Gene pairs that often co-occur in the same decision trees and are most important for
classification are shown in blue. Node color indicates protein importance whereas edge width indicates the importance of a protein combination. (B)
Enrichment for developmentally-related phenotype categories in the MGI database (FDR is reported above each bar). (C) Enrichment of germ-layer
specific genes identified by NGF based on the Gene Ontology (FDR is reported above each bar). (D) Percentage of genes, interactions, and modules
that were reproduced based on an independent dataset. (E) Percent of reproduced single genes and gene combinations (Fisher’s Exact Test P-values
are reported). NGF* indicates the result for NGF applied to networks with perturbed expression measurements.
doi:10.1371/journal.pcbi.1002180.g003
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Previous efforts to mine networks for differentially-expressed
modules have assumed that module activity can be represented with
a single functional form. This hypothesis is expressed in the scoring
function that is applied to each module to assess its differential
activity. However,ouranalysisof a representativesample ofdiseases
and developmental programs indicates that the most effective
decision functions are in fact not homogeneous, but involve a
combination of coherent and opposing gene-gene interactions.
While the biological programs covered in this paper are
certainly not a comprehensive survey of molecular decision-
making, it is significant that both the developmental and cancer
modules lead to similar conclusions. First, the network signatures
identified by NGF are robust as evidenced by their support from
multiple independent datasets. Of the development modules
reported by NGF, 83% are reproduced across developmental
datasets, in contrast to 0% reproduced by a network-free
approach. In breast cancer, we observed a 73% correlation
between the features selected for breast cancer, in contrast to 1%
for a network-free approach.
Second, while the overall classification performance of NGF
does not differ from regular Random Forests, network informa-
tion does achieve sharp focus on genes and gene combinations
that are close to the causes of development or disease. A known
difficulty with classification using molecular profiles is that it is
possible to construct many alternative classifiers all of which have
equivalent performance but are based on very different sets of
genes [51,52]. This is due to the relatively small number of
samples as well as the large number of genes that are correlated
with outcome. Among the many alternative classifiers, some rely
on genes that are close to the true disease mechanisms, while
most rely on distantly associated genes. NGF constrains the
selected gene features to fall into contiguous protein interaction
subnetworks. These network-derived features are more repro-
ducible and strongly enriched in the expected gene functions:
Developmental modules are highly enriched for development,
and cancer modules are highly enriched for known cancer
susceptibility factors. Thus the prior knowledge of the protein
interactions serves to filter the set of all possible classifiers [53]
allowing NGF to identify those that are based on biologically
relevant markers.
Finally, network analysis reveals how single factors form
predictive combinations. In development, NGF identifies a concise
network of HOX genes interacting with developmentally impor-
tant cofactors, whose tissue-specific roles are just beginning to be
illuminated [37,54]. In cancer, combinations of interacting
oncogenes and tumor suppressors are found such that their
combined activity determines disease outcome. Beyond develop-
ment and cancer, it is likely that for many biological programs,
molecular interaction networks will provide a useful framework to
guide computational approaches towards biologically-relevant and
reproducible genetic logic.
Figure 5. Network functions underlying cancer progression. (A) The decision trees for mesenchymal transformation are dissected by
assigning their gene pairs to one of three functional categories based on the sign of gene expression in predicting the more aggressive phenotype.
The percentage of gene pairs assigned to each of the three functional categories is shown as a function of the score threshold used for selecting gene
pairs. Accuracy is calculated as the average Laplace score (Text S1) over all trees in the forest. (B) Enrichment for interactions between oncogenes,
between tumor suppressors and between an oncogene and a tumor suppressor among functional categories identified using NGF. Percent of such
interactions among top scoring pairs in each functional category is reported along with the Fisher’s Exact Test P-value of enrichment.
doi:10.1371/journal.pcbi.1002180.g005
Figure 4. Classification performance and validation of markers of breast cancer metastasis. (A) Average area under the ROC curve for
NGF, RF, NGF applied to permuted networks (NGF**), and Naı ¨ve Bayes, compared to reported scores for representative previous methods (error bars
denote standard deviation estimated over 100 runs). (B) General cancer and breast cancer associated genes identified among the 100 top-scoring
genes or 100 most abundant genes in the forest created using RF or NGF. using the real network or networks with permuted edges (average over 100
permutations is shown). (C) Genes ranked by their importance for classification in two independent breast cancer patient cohorts (y vs. x axis).
Network-Guided Forest, blue points; regular Random Forest, green points.
doi:10.1371/journal.pcbi.1002180.g004
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Datasets
Detailed information on gene expression and protein-protein
interaction datasets is provided in Table S1. Phenotypes
associated with genetic perturbations in mouse (Figure 3B) were
downloaded from the MGI database [55]. Cancer-associated
genes (including breast and brain cancer genes) were from the
Genetic Association Database [56] and were downloaded from
DAVID [57]. Lists of tumor suppressors and oncogenes were
downloaded from the Cancer Genes database [58].
Network-Guided Forests
NGF is a network-based supervised learning algorithm that
constructs an ensemble of decision trees which vote to determine
the class of a sample. As in the standard Random Forests
algorithm, each tree is constructed based on a bootstrap subset of
samples drawn with replacement from the original training set.
The individual trees are built using the recursive partitioning
algorithm CART (Classification And Regression Trees) [59].
CART uses a measure of impurity called the Gini index to
determine how well a gene and a corresponding expression
threshold can differentiate samples with respect to their pheno-
typic class. The best such gene establishes the first split in the tree.
Samples for which the expression value for the selected gene is
lower than the threshold are assigned to the left child node in the
tree and those with values higher than or equal to the threshold
are put in the right child node. This process is iterated for each
child node until the improvement in class separation (as measured
by the Gini index) is lower than e (here we use e=0.02 or e=0.01
for the global and transcription factor-specific network, respec-
tively). In NGF, as in Random Forests, the search process applied
by CART is randomized to allow for multiple concurrent trees to
be built. First, each tree root is selected as the best gene among a
random subset of size !N, where N is the number of all considered
genes. Then, at each subsequent node in the tree, the best splitting
gene is selected among a random candidate set. NGF selects the
candidate set among network neighbors of genes already present
in the tree. To promote the identification of dense subnetworks,
the roots are required to have at least k network neighbors (here
k=5) and the candidate set of subsequent nodes is expanded
iteratively, where each time the probability of selecting a given
gene for the candidate set is proportional to the number of
interactions it shares with genes already in the tree. NGF also
requires that each gene appears at most once on each path from
the root to the leaf of the tree. After the trees are constructed, the
entire forest is used to determine the class of a new sample. For
each tree, the sample is propagated down from the root of the tree
and assigned to one of the leaves according to the series of splitting
conditions along the path leading from root to leaf. The
probability of a given class is determined based on the proportion
of training samples that were initially assigned to this leaf. The
average probability across all trees is computed and the value of
this score is used to determine sample class. Different score
thresholds can be used to trade-off specificity and sensitivity.
Identifying network decision modules
Following [31], we use samples that were not selected to
construct a given tree (so called ‘‘out-of-bag’’ samples) to estimate
the misclassification error of the tree and determine feature
importance. Specifically, we use each tree to classify the
corresponding out-of-bag samples and report the percentage of
samples misclassified. Next, for each gene in the tree, we measure
the increase in the misclassification error resulting from permuting
the expression measurements for this gene in the out-of-bag
samples. The mean increase of this error over all trees determines
the importance score of each gene (trees in which a gene was not
used are counted and contribute 0 to the mean). An analogous
approach is used to determine the importance scores for pairs of
genes. For this we calculate the mean increase in tree
misclassification error caused by permuting expression values of
any two genes which are used by a particular tree (see [35,36,60]
for related techniques applied for standard decision tree
ensembles). To construct network decision modules, NGF outputs
the top scoring genes and gene pairs which have a False Discovery
Rate (FDR) , 0.05, where the null distribution is estimated by
executing NGF 100 times on data with permuted class labels. The
stability of this procedure increases with the number of trees in the
forest. For datasets used here, we found that the method produces
robust results provided that the forest contains . 20,000 trees. For
gene pairs, we additionally check that the mean increase in the
misclassification error for the pair is significantly greater than for
any single gene in that pair in trees where both genes are present
(FDR,0.05). Genes with significant importance scores either
independently or in combination with other genes are clustered
based on how often they co-appear in the same decision trees. To
this end we apply the affinity propagation algorithm [61] which is
implemented as a plugin for Cytoscape [62,63].
Functional enrichment analysis
Gene Ontology enrichment analysis was performed using
DAVID [57]. MGI phenotype enrichment and enrichment for
cancer genes was calculated using Fisher’s Exact Test implement-
ed in R (http://www.R-project.org). All enrichments were
calculated with respect to the background of all genes present in
the input protein-protein interaction network used in each study.
Supporting Information
Figure S1 Modules, decision trees and logic functions.
The logic functions behind key modules for breast cancer
metastasis (A) or brain tumors (B) are represented using decision
trees and truth tables. In each case the gene is interpreted as being
up-regulated if its expression is above the threshold. Otherwise the
gene is down-regulated. Each path from root to leaf in the tree
maps to a different row in the truth table. Decision trees are
typically not grown to the full extent and thus not all genes must be
tested along each path if a subset of the genes is sufficient to
determine the output.
(TIF)
Figure S2 Gene Ontology enrichment analysis. Genes in
the network identified by NGF (Figure 3A) are enriched for
important developmental processes catalogued in the Gene
Ontology. FDR is indicated above each bar.
(TIF)
Figure S3 Robustness of NGF results in cross validation
runs. The average percentage of the top 50 proteins and top 50
protein pairs identified for the developmental case study (A), the
breast cancer metastasis case study (B) or the brain tumor case
study (C) that were reproduced on datasets with 10% of the data
held-out. Error bars indicate standard deviations estimated over
100 runs.
(TIF)
Figure S4 Overlap between NGF results based on
Ravasi and Muller datasets. (A) Network modules identified
using NGF based on the Ravasi dataset were limited to genes
available also in the Muller dataset. Large modules (3 or more
Protein Networks as Logic Functions
PLoS Computational Biology | www.ploscompbiol.org 9 September 2011 | Volume 7 | Issue 9 | e1002180proteins) are encircled. (B) Overlapping genes and interactions
identified based on the Muller dataset. Conserved large modules
for which at least one interaction is retained in the result based on
the Muller dataset are encircled.
(TIF)
Figure S5 ROC analysis. Representative ROC curves for
NGF, RF and NGF applied to networks with permuted edges
(NGF**) for classification of breast cancer metastasis (A) and brain
tumors (B). The average probability of a class computed across all
trees in the forest is used as a parameter to trade off sensitivity and
specificity.
(TIF)
Figure S6 Classification performance and validation of
network markers of mesenchymal transformation. (A)
Average area under the ROC curve for NGF, RF, NGF applied to
networks with permuted edges (NGF**), and Naı ¨ve Bayes (error
bars denote standard deviation estimated over 100 runs). (B)
Cancer and brain cancer associated genes identified among 100
top-scoring genes or 100 most abundant genes in the forest created
using RF or NGF using the real network or networks with
permuted edges (NGF**, average over 100 permutations is
shown).
(TIF)
Figure S7 Network functions underlying development
and cancer progression. For each study, the percentage of
gene pairs assigned to each of the three functional categories is
shown as a function of the score threshold used for selecting gene
pairs. Accuracy is calculated as the average Laplace score over all
trees in the forest (Text S1).
(TIF)
Table S1 Protein-protein interaction networks and transcrip-
tional profiles used in this study.
(DOC)
Table S2 Predictive interactions between known oncogenes and
tumor suppressors identified among top-scoring gene pairs from
the NGF analysis.
(XLS)
Text S1 Supplementary methods.
(DOC)
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